99% CAS 93106-60-6 Dog Antibiotic Enrofloxacin Powder For Poultry 359.395

CAS 93106-60-6 Veterinary API antibiotics Enrofloxacin

Related product:

The Introductction of Enrofloxacin:

Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

The Application & Function of Enrofloxacin:

Enrofloxacin for tuberculosis mycoplasma (chronic respiratory disease), avian mycosis, chicken white diarrhea, avian salmonellosis, Pasteurellosis, piglet white diarrhea, yellow dysentery, large pig edema type E. coli disease, pig Of mycoplasma swollen bronchial pneumonia, pleural pneumonia, piglet paratyphoid, and cattle, sheep, rabbits, dogs and other mycoplasma and bacterial diseases, can also be used for various types of aquatic animals, bacterial infection.

Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 The COA of Enrofloxacin :